Article
Evaluation of the genome-informed risk assessment (GIRA) approach from eMERGE in an independent health system
2026-02-27
Abstract excerpt
The Genome Informed Risk Assessment (GIRA) from eMERGE is an ongoing pragmatic prospective study designed to implement and evaluate genomic precision medicine across diverse clinical settings. Here, we examine the utility of the high-risk criteria from GIRA in assessing health risk through a retrospective evaluation of 9 adult conditions in a health system independent of eMERGE using the Penn Medicine Biobank (PMB...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 3b63880f-7888-5d8f-af56-8f55a28dce11
- DOI
- 10.64898/2026.02.25.26347123
